Publicação

Long-term survival in multiple myeloma.

Ver documento

Detalhes bibliográficos
Resumo:KEY CLINICAL MESSAGE: The survival of multiple myeloma patients has improved very significantly over the last decade. Still median overall survival is inferior to 5 years. A small proportion of patients survive longer than 10 years. In this paper we discuss four cases illustrating the nonhomogeneous clinical presentation and evolution of this subset of patients. Surprisingly, these long survivors do not always have deep responses and some require frequent treatments, which include autologous stem cell transplantation and novel drugs. The authors discuss several aspects of these clinical histories, including treatment options, raising hypothesis on their relation with long survivorship which may be important to have in consideration when studying this subject.
Autores principais:João, C
Outros Autores:Costa, C; Coelho, I; Vergueiro, MJ; Ferreira, M; Silva, MG
Assunto:Multiple myeloma Survival analysis Prognosis
Ano:2014
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Hospital Prof. Dr. Fernando Fonseca E.P.E.
Idioma:português
Origem:Repositório do Hospital Prof. Doutor Fernando Fonseca
_version_ 1868417267238174720
author João, C
author2 Costa, C
Coelho, I
Vergueiro, MJ
Ferreira, M
Silva, MG
author2_role author
author
author
author
author
author_facet João, C
Costa, C
Coelho, I
Vergueiro, MJ
Ferreira, M
Silva, MG
author_role author
contributor_name_str_mv Unidade Local de Saúde Amadora / Sintra
country_str PT
creators_json_txt [{\"Person.name\":\"João, C\"},{\"Person.name\":\"Costa, C\"},{\"Person.name\":\"Coelho, I\"},{\"Person.name\":\"Vergueiro, MJ\"},{\"Person.name\":\"Ferreira, M\"},{\"Person.name\":\"Silva, MG\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Unidade Local de Saúde Amadora / Sintra
datacite.creators.creator.creatorName.fl_str_mv João, C
Costa, C
Coelho, I
Vergueiro, MJ
Ferreira, M
Silva, MG
datacite.date.Accepted.fl_str_mv 2014-01-01T00:00:00Z
datacite.date.available.fl_str_mv 2015-04-22T14:57:24Z
datacite.date.embargoed.fl_str_mv 2015-04-22T14:57:24Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Multiple myeloma
Survival analysis
Prognosis
datacite.titles.title.fl_str_mv Long-term survival in multiple myeloma.
dc.contributor.none.fl_str_mv Unidade Local de Saúde Amadora / Sintra
dc.creator.none.fl_str_mv João, C
Costa, C
Coelho, I
Vergueiro, MJ
Ferreira, M
Silva, MG
dc.date.Accepted.fl_str_mv 2014-01-01T00:00:00Z
dc.date.available.fl_str_mv 2015-04-22T14:57:24Z
dc.date.embargoed.fl_str_mv 2015-04-22T14:57:24Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10400.10/1415
dc.language.none.fl_str_mv por
dc.publisher.none.fl_str_mv John Wiley & Sons
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Multiple myeloma
Survival analysis
Prognosis
dc.title.fl_str_mv Long-term survival in multiple myeloma.
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description KEY CLINICAL MESSAGE: The survival of multiple myeloma patients has improved very significantly over the last decade. Still median overall survival is inferior to 5 years. A small proportion of patients survive longer than 10 years. In this paper we discuss four cases illustrating the nonhomogeneous clinical presentation and evolution of this subset of patients. Surprisingly, these long survivors do not always have deep responses and some require frequent treatments, which include autologous stem cell transplantation and novel drugs. The authors discuss several aspects of these clinical histories, including treatment options, raising hypothesis on their relation with long survivorship which may be important to have in consideration when studying this subject.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://repositorio.hff.min-saude.pt/bitstreams/b30c715b-3706-4c68-ba92-e135a9a1bdf4/download
id rhff_120ca2bab3ba41d84dffccf8a4250e22
identifier.url.fl_str_mv http://hdl.handle.net/10400.10/1415
instacron_str hff
institution Hospital Prof. Dr. Fernando Fonseca E.P.E.
instname_str Hospital Prof. Dr. Fernando Fonseca E.P.E.
language por
network_acronym_str rhff
network_name_str Repositório do Hospital Prof. Doutor Fernando Fonseca
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/1415
organization_str_mv urn:organizationAcronym:hff
person_str_mv João, C
Costa, C
Coelho, I
Vergueiro, MJ
Ferreira, M
Silva, MG
publishDate 2014
publisher.none.fl_str_mv John Wiley & Sons
reponame_str Repositório do Hospital Prof. Doutor Fernando Fonseca
repository_id_str urn:repositoryAcronym:rhff
service_str_mv urn:repositoryAcronym:rhff
spelling porJohn Wiley & SonsporKEY CLINICAL MESSAGE: The survival of multiple myeloma patients has improved very significantly over the last decade. Still median overall survival is inferior to 5 years. A small proportion of patients survive longer than 10 years. In this paper we discuss four cases illustrating the nonhomogeneous clinical presentation and evolution of this subset of patients. Surprisingly, these long survivors do not always have deep responses and some require frequent treatments, which include autologous stem cell transplantation and novel drugs. The authors discuss several aspects of these clinical histories, including treatment options, raising hypothesis on their relation with long survivorship which may be important to have in consideration when studying this subject.application/pdfporLong-term survival in multiple myeloma.João, CCosta, CCoelho, IVergueiro, MJFerreira, MSilva, MGHostingInstitutionOrganizationalUnidade Local de Saúde Amadora / Sintrae-mailmailto:repositorio@hff.min-saude.ptrepositorio@hff.min-saude.ptDOIIsPartOf10.1002/ccr3.762015-04-22T14:57:24Z20142014-01-01T00:00:00ZHandlehttp://hdl.handle.net/10400.10/1415http://purl.org/coar/access_right/c_abf2open accessMultiple myelomaSurvival analysisPrognosis75817 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal articlehttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://repositorio.hff.min-saude.pt/bitstreams/b30c715b-3706-4c68-ba92-e135a9a1bdf4/downloadClinical case reports2173179Chichester
spellingShingle Long-term survival in multiple myeloma.
João, C
Multiple myeloma
Survival analysis
Prognosis
status SINGLETON
subject.fl_str_mv Multiple myeloma
Survival analysis
Prognosis
title Long-term survival in multiple myeloma.
title_full Long-term survival in multiple myeloma.
title_fullStr Long-term survival in multiple myeloma.
title_full_unstemmed Long-term survival in multiple myeloma.
title_short Long-term survival in multiple myeloma.
title_sort Long-term survival in multiple myeloma.
topic Multiple myeloma
Survival analysis
Prognosis
topic_facet Multiple myeloma
Survival analysis
Prognosis
url http://hdl.handle.net/10400.10/1415
visible 1